EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Healius's enterprise value is $1,251 Mil.
Healius's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1,015 Mil. Therefore, Healius's EV-to-Revenue for today is 1.23.
The historical rank and industry rank for Healius's EV-to-Revenue or its related term are showing as below:
PHCRF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.07 Med: 1.59 Max: 2.79
Current: 1.28
During the past 13 years, the highest EV-to-Revenue of Healius was 2.79. The lowest was 1.07. And the median was 1.59.
PHCRF's EV-to-Revenue is ranked better than 79.52% of 210
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.77
vs PHCRF: 1.28
As of today (2025-05-29), Healius's stock price is $0.84.
Healius's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $1.49. Therefore, Healius's PS Ratio for today is 0.56.
Healius EV-to-Revenue Historical Data
The historical data trend for Healius's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Healius's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healius's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Healius's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Healius's EV-to-Revenue falls into.
Healius's current Enterprise Value is $1,251 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Healius's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1,015 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healius's share price for today is $0.84.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was $1.49.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healius EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Healius's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PHCRF has been successfully added to your 